FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2608396028> ?p ?o ?g. }

• W2608396028 endingPage "260" @default.
• W2608396028 startingPage "251" @default.
• W2608396028 abstract "Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis Jack Burks,1 Thomas S Marshall,2 Xiaolan Ye2 1Nova Southeastern University, Davie, FL, 2AbbVie Inc, Chicago, IL, USA Purpose: To evaluate adherence to disease-modifying therapies (DMTs) among patients with multiple sclerosis (MS) initiating oral and injectable DMTs, and to estimate the impact of adherence on relapse, health resource utilization, and medical costs.Patients and methods: Commercially insured MS patients (aged 18–65 years, two or more MS diagnoses, one or more DMT claims) with continuous eligibility 12 months before and after the first DMT claim date (index date) and no DMT claim during the pre-index period were identified from a large commerical claims database for the period from January 1, 2008, to September 30, 2015. Adherence to the index DMT was measured by the 12-month post-index proportion of days covered (PDC) and compared between oral and injectable DMT initiators. After adjustment for sex, age at index DMT, and comorbidities, regression models examined the relationship between adherence and relapse risk, MS-related health resource utilization, and non-drug medical costs (2015 US$).Results: The study covered 12,431 patients and nine DMTs. Adherence to the index DMT did not differ significantly between oral (n=1,018) and injectable (n=11,413) DMTs when assessed by mean PDC (0.7257±0.2934 vs 0.7259±0.2869, respectively; P=0.0787), or percentages achieving PDC ≥0.8 (61.4% vs 58.6%, respectively; P=0.0806). Compared to non-adherence, adherence to DMT significantly reduced the likelihood of relapse in the post-index 12 months by 42%, hospitalization by 52%, and emergency visits by 38% (all, P<0.0001). Adherent patients would be expected to have on average 0.7 fewer outpatient visits annually versus non-adherent patients (P<0.0001). Based on the differences in predicted mean costs, adherence (vs non-adherence) would decrease the total annual medical care costs by $5,816 per patient, including hospitalization costs by $1,953, emergency visits by $171, and outpatient visits by $2,802.Conclusion: Adherence remains suboptimal but comparable between oral and injectable DMTs. Potential health and economic benefits underscore the importance of improving adherence in MS. Keywords: MS, DMT prescribing patterns, implications" @default.
• W2608396028 created "2017-05-05" @default.
• W2608396028 creator A5032326673 @default.
• W2608396028 creator A5041999825 @default.
• W2608396028 creator A5069405246 @default.
• W2608396028 date "2017-04-01" @default.
• W2608396028 modified "2023-10-02" @default.
• W2608396028 title "Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis" @default.
• W2608396028 cites W134576514 @default.
• W2608396028 cites W1533537857 @default.
• W2608396028 cites W1573130413 @default.
• W2608396028 cites W1581887055 @default.
• W2608396028 cites W1966515383 @default.
• W2608396028 cites W1969523085 @default.
• W2608396028 cites W1982508920 @default.
• W2608396028 cites W1984705645 @default.
• W2608396028 cites W2000445173 @default.
• W2608396028 cites W2012040225 @default.
• W2608396028 cites W2014094373 @default.
• W2608396028 cites W2019181818 @default.
• W2608396028 cites W2038982872 @default.
• W2608396028 cites W2043591841 @default.
• W2608396028 cites W2043729729 @default.
• W2608396028 cites W2060605559 @default.
• W2608396028 cites W2061166054 @default.
• W2608396028 cites W2062557300 @default.
• W2608396028 cites W2071099718 @default.
• W2608396028 cites W2079246512 @default.
• W2608396028 cites W2082422372 @default.
• W2608396028 cites W2095712666 @default.
• W2608396028 cites W2103758700 @default.
• W2608396028 cites W2112640398 @default.
• W2608396028 cites W2123061840 @default.
• W2608396028 cites W2123156857 @default.
• W2608396028 cites W2127008375 @default.
• W2608396028 cites W2127183200 @default.
• W2608396028 cites W2129168200 @default.
• W2608396028 cites W2130437068 @default.
• W2608396028 cites W2143953700 @default.
• W2608396028 cites W2148186809 @default.
• W2608396028 cites W2148455753 @default.
• W2608396028 cites W2151516700 @default.
• W2608396028 cites W2157815127 @default.
• W2608396028 cites W2169394319 @default.
• W2608396028 cites W2179093540 @default.
• W2608396028 cites W2289614658 @default.
• W2608396028 cites W2311072866 @default.
• W2608396028 cites W2346221108 @default.
• W2608396028 cites W2402638249 @default.
• W2608396028 cites W2509107095 @default.
• W2608396028 cites W2510383943 @default.
• W2608396028 cites W2555603121 @default.
• W2608396028 cites W2704729794 @default.
• W2608396028 cites W33609267 @default.
• W2608396028 doi "https://doi.org/10.2147/ceor.s130334" @default.
• W2608396028 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5417677" @default.
• W2608396028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28496344" @default.
• W2608396028 hasPublicationYear "2017" @default.
• W2608396028 type Work @default.
• W2608396028 sameAs 2608396028 @default.
• W2608396028 citedByCount "92" @default.
• W2608396028 countsByYear W26083960282017 @default.
• W2608396028 countsByYear W26083960282018 @default.
• W2608396028 countsByYear W26083960282019 @default.
• W2608396028 countsByYear W26083960282020 @default.
• W2608396028 countsByYear W26083960282021 @default.
• W2608396028 countsByYear W26083960282022 @default.
• W2608396028 countsByYear W26083960282023 @default.
• W2608396028 crossrefType "journal-article" @default.
• W2608396028 hasAuthorship W2608396028A5032326673 @default.
• W2608396028 hasAuthorship W2608396028A5041999825 @default.
• W2608396028 hasAuthorship W2608396028A5069405246 @default.
• W2608396028 hasBestOaLocation W26083960281 @default.
• W2608396028 hasConcept C126322002 @default.
• W2608396028 hasConcept C194828623 @default.
• W2608396028 hasConcept C203014093 @default.
• W2608396028 hasConcept C2779134260 @default.
• W2608396028 hasConcept C2780640218 @default.
• W2608396028 hasConcept C71924100 @default.
• W2608396028 hasConceptScore W2608396028C126322002 @default.
• W2608396028 hasConceptScore W2608396028C194828623 @default.
• W2608396028 hasConceptScore W2608396028C203014093 @default.
• W2608396028 hasConceptScore W2608396028C2779134260 @default.
• W2608396028 hasConceptScore W2608396028C2780640218 @default.
• W2608396028 hasConceptScore W2608396028C71924100 @default.
• W2608396028 hasLocation W26083960281 @default.
• W2608396028 hasLocation W26083960282 @default.
• W2608396028 hasLocation W26083960283 @default.
• W2608396028 hasLocation W26083960284 @default.
• W2608396028 hasLocation W26083960285 @default.
• W2608396028 hasOpenAccess W2608396028 @default.
• W2608396028 hasPrimaryLocation W26083960281 @default.
• W2608396028 hasRelatedWork W2034669414 @default.
• W2608396028 hasRelatedWork W2088377755 @default.
• W2608396028 hasRelatedWork W2338718586 @default.
• W2608396028 hasRelatedWork W2617222556 @default.
• W2608396028 hasRelatedWork W2625825622 @default.
• W2608396028 hasRelatedWork W2997255441 @default.

• next